-
Mashup Score: 3Helping Patients With Lymphoma Live Not Only Longer, But Better - 14 day(s) ago
Helping Patients With Lymphoma Live Not Only Longer, But Better As the daughter of a Malaysian diplomat and an international environmental lawyer, Gita
Source: lymphoma.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2The U.S. Food and Drug Administration (FDA) Approves Brentuximab Vedotin with Lenalidomide and Rituximab for Relapsed or Refractory Large B-cell Lymphoma - 2 month(s) ago
Latest News The U.S. Food and Drug Administration (FDA) Approves Brentuximab Vedotin with Lenalidomide and Rituximab for Relapsed or Refractory Large
Source: lymphoma.orgCategories: General Medicine News, Oncologists1Tweet-
On Feb. 12, the FDA announced it has approved brentuximab vedotin (Adcetris, Seagen Inc., a subsidiary of Pfizer) in combination with lenalidomide and a rituximab product for adult patients with relapsed or refractory large B-cell lymphoma (LBCL): https://t.co/zaChdL2Za3 https://t.co/Zt0YkmLTyn
-
-
Mashup Score: 5Lymphoma Walks - 2 month(s) ago
Patients, survivors, care partners, and friends come together at Lymphoma Walks in honor and memory of those whose lives have been touched by lymphoma.
Source: lymphoma.orgCategories: General Medicine News, Oncologists1Tweet-
When we walk together, we make great things possible. Join us at a Lymphoma Walk this spring and summer and help us get one step closer to a cure - get started by finding a walk near you: https://t.co/Ac1PIpPbha https://t.co/7BmdqeSKPW
-
-
Mashup Score: 4Support Services - 2 month(s) ago
The Lymphoma Research Foundation (LRF) offers a wide range of support services, for people with lymphoma and their loved ones.
Source: lymphoma.orgCategories: General Medicine News, Onc News and JournalsTweet-
Today on #WorldCancerDay, we're continuing our work to #CloseTheCareGap. LRF’s support services are here to provide lymphoma patients and caregivers the tools they need to navigate the journey ahead: https://t.co/Ah3FdJLfbT https://t.co/mvQOM1NYsU
-
-
Mashup Score: 4Lymphoma Rounds: New York – September 14, 2023 - 2 month(s) ago
Time: Networking 6:00 PM – 7:00 PM ET Program 7:00 PM – 8:30 PM ET
Source: lymphoma.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our New York Lymphoma Rounds are just a month away! Join us in New York City on September 14 to learn the latest on lymphoma and network with fellow area physicians at this free continuing medical education program. To learn more and to register, visit: https://t.co/kXOwAUrZtK
-
-
Mashup Score: 1Laura, Marginal Zone Lymphoma - 2 month(s) ago
Laura, Marginal Zone Lymphoma In late 2018, I was 60 years old and had been losing weight and working on getting into better shape. At Thanksgiving, my
Source: lymphoma.orgCategories: General Medicine News, Oncologists1Tweet-
5 years after being diagnosed with marginal zone lymphoma (MZL), Laura has founded a support group for fellow patients and looks to the Foundation's focus on research to continue to develop new treatments for those like her: https://t.co/1i8c6WFB2f https://t.co/9DB4HE6iK5
-
-
Mashup Score: 2Getting a Second Opinion - 2 month(s) ago
Before starting any type of treatment, a patient may consider getting a second opinion–especially if some characteristics of the diagnosis are complicated or uncertain.
Source: lymphoma.orgCategories: General Medicine News, Oncologists1Tweet-
Wondering if you should seek a second opinion after being diagnosed with lymphoma? Getting a second opinion can help to ensure your treatment plan is the best fit for you and deepen your understanding of your diagnosis: https://t.co/o2Hh8Ve9Nf https://t.co/pcruvVmQ75
-
-
Mashup Score: 2The U.S. Food and Drug Administration (FDA) Approves Acalabrutinib (Calquence) for Mantle Cell Lymphoma - 3 month(s) ago
Latest News The U.S. Food and Drug Administration (FDA) Approves Acalabrutinib (CALQUENCE) for Mantle Cell Lymphoma January 16, 2025 – On January 16,
Source: lymphoma.orgCategories: General Medicine News, Oncologists1Tweet-
On Jan. 16, 2025, the FDA announced it has approved acalabrutinib (CALQUENCE, AstraZeneca) with bendamustine and rituximab for adults with previously untreated mantle cell lymphoma who are ineligible for autologous hematopoietic stem cell transplantation: https://t.co/mslHdiqELV https://t.co/GgVuVd7Lge
-
-
Mashup Score: 2Bob, Follicular Lymphoma Survivor - 3 month(s) ago
Bob, Follicular Lymphoma Survivor Bob took reasonable care of himself in his late 40’s. He swam every other day, played softball, played racquetball, and
Source: lymphoma.orgCategories: General Medicine News, Oncologists1Tweet-
Read more about the advances that Lymphoma Research Foundation Ambassador Bob has seen since his follicular lymphoma diagnosis in 1998, and how the Foundation plays a major role in moving lymphoma research forward in his Story of Hope: https://t.co/73uFwqcXts https://t.co/tObSwNDyT6
-
-
Mashup Score: 4Support Services - 3 month(s) ago
The Lymphoma Research Foundation (LRF) offers a wide range of support services, for people with lymphoma and their loved ones.
Source: lymphoma.orgCategories: General Medicine News, Onc News and JournalsTweet-
Today on #WorldCancerDay, we're continuing our work to #CloseTheCareGap. LRF’s support services are here to provide lymphoma patients and caregivers the tools they need to navigate the journey ahead: https://t.co/Ah3FdJLfbT https://t.co/mvQOM1NYsU
-
Dr. Gita Thanarajasingam (@MayoClinic) is pioneering a patient-centered approach to lymphoma treatment. With a global upbringing & a passion for medicine, she's dedicated to improving treatment tolerability & understanding the patient experience: https://t.co/Bm5H9scouF https://t.co/xbDYT6vU3L